BABA
Alibaba Group Holding Limited
BABA has a slight edge over CALY overall, supported by lower modeled downside.
CALY
Callaway Golf Company
CALY offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
BABA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Weak | |
| Healthy |
BABA's balance sheet is currently healthy, and its revenue is stable, but its profitability and cash flow are under pressure.
CALY Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Stable | |
| Strong | |
| Strong |
CALY's cash flow and balance sheet are currently strong, and its profitability is stable, but its revenue is weak.
BABA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 16x | $69.66 | -26% |
| Fair | 20x | $86.59 | -8.2% |
| Current | 21x | $94.36 | — |
| Expensive | 26x | $115 | +22% |
Historical ranges are pointers, not guarantees.
BABA's PE is 21x, but its earnings don't support one, so it isn't a reliable read right now.
CALY PE Valuation
CALY has no meaningful PE right now: it lost money over the past year.
BABA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
BABA has the edge over CALY on the outlook, with more favorable revenue expectations.
CALY Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Decline | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect CALY's earnings to grow and its profitability to improve, but its revenue to decline. However, they disagree widely on these estimates.
BABA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $4.42 | -52% |
| Q1 2026 | $6.57 | -18% |
| Q4 2025 | $5.79 | -22% |
| Q3 2025 | $7.85 | +49% |
| Q2 2025 | $9.27 | +116% |
| Q1 2025 | $8.06 | +71% |
| Q4 2024 | $7.47 | +24% |
| Q3 2024 | $5.26 | -35% |
BABA has the edge over CALY on earnings quality, reporting a profit while its opponent remains loss making.
CALY Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.98 | — |
| Q3 2026 | -$1.15 | +$7.03 |
| Q2 2026 | -$1.48 | +$6.64 |
| Q1 2026 | -$1.77 | +$6.14 |
| Q4 2025 | -$2.23 | +$5.65 |
| Q3 2025 | -$8.18 | -$8.14 |
| Q2 2025 | -$8.12 | -5900% |
| Q1 2025 | -$7.91 | -2029% |
| Q4 2024 | -$7.88 | -1676% |
CALY is still losing money, but far less than before: $1.15 per share over the past year, against $8.18 at its worst in late 2025.
BABA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $40.2B | +8.3% |
| Q1 2026 | $36.5B | +2.9% |
| Q4 2025 | $42.7B | +1.7% |
| Q3 2025 | $37.2B | +4.8% |
| Q2 2025 | $37.2B | +1.8% |
| Q1 2025 | $35.5B | +6.6% |
| Q4 2024 | $42B | +7.6% |
| Q3 2024 | $35.5B | +5.2% |
BABA has the edge over CALY on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 7.2% | -6.9 points |
| Q1 2026 | -0.3% | -12 points |
| Q4 2025 | 7.1% | -7.6 points |
| Q3 2025 | 2.2% | -13 points |
| Q2 2025 | 14% | -0.7 points |
| Q1 2025 | 12% | +5.4 points |
| Q4 2024 | 15% | +6.1 points |
| Q3 2024 | 15% | 0 points |
BABA's operating margin was 7.2% last quarter, down 6.9 points from the same quarter a year ago.
CALY Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $436.9M | -53% |
| Q2 2026 | $612.2M | -45% |
| Q1 2026 | $687.5M | -37% |
| Q4 2025 | $367.5M | -60% |
| Q3 2025 | $934M | -7.8% |
| Q2 2025 | $1.1B | -4.1% |
| Q1 2025 | $1.1B | -4.5% |
| Q4 2024 | $924.4M | +3% |
CALY's revenue has slid since its 2023 peak: $437M last quarter, down 53% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 10% | +7.2 points |
| Q2 2026 | 19% | +9.2 points |
| Q1 2026 | 20% | +14 points |
| Q4 2025 | -15% | +143 points |
| Q3 2025 | 3% | -0.3 points |
| Q2 2025 | 9.5% | +0.6 points |
| Q1 2025 | 6.1% | +0.2 points |
| Q4 2024 | -158% | -154 points |
CALY has the edge over BABA on profitability, with a higher operating margin.
BABA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$6.7B | -$4.1B |
| Q1 2026 | -$2.7B | +$1.5B |
| Q4 2025 | $1B | -90% |
| Q3 2025 | -$3.2B | -254% |
| Q2 2025 | -$2.7B | -182% |
| Q1 2025 | -$4.2B | -12231% |
| Q4 2024 | $10.4B | -4.8% |
| Q3 2024 | $2.1B | -62% |
BABA's free cash flow has turned negative after years in the green: −$11.6B over the past year.
CALY Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $180.8M | +12% |
| Q2 2026 | $238.1M | +354% |
| Q1 2026 | -$176M | -$20.9M |
| Q4 2025 | $242.7M | +$267.7M |
| Q3 2025 | $162.1M | +48% |
| Q2 2025 | $52.5M | -63% |
| Q1 2025 | -$155.1M | -$16.4M |
| Q4 2024 | -$25M | -157% |
CALY has the edge over BABA on cash generation, producing positive trailing cash flow while its opponent burns cash.
BABA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.5% | +11.1M shares |
| 1 year | +0.9% | +21.4M shares |
| 3 years | -6.2% | -161M shares |
| 5 years | -12% | -339M shares |
| Available history | -8.4% | -221M shares |
BABA has 2.4B diluted shares, up 0.9% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | $269.8M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
BABA spent $270M buying back its own shares over the past year, after none the year before.
CALY Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -3.6% | -6.8M shares |
| 1 year | -0.3% | -600K shares |
| 3 years | -8.9% | -17.9M shares |
| 5 years | -1.4% | -2.7M shares |
| Available history | +90% | +87M shares |
CALY has the edge over BABA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $50.7M |
| Q2 2026 | $42.5M |
| Q1 2026 | $42M |
| Q4 2025 | $300,000 |
| Q3 2025 | $100,000 |
| Q2 2025 | — |
| Q1 2025 | $3.3M |
| Q4 2024 | — |
CALY spent $136M buying back its own shares over the past year, more than ten times what it spent the year before.
BABA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 0.6x | Very low |
| Q3 2025 | 0.8x | Very low |
| Q2 2025 | 0.2x | Very low |
| Q1 2025 | 0.3x | Very low |
| Q4 2024 | 0.1x | Very low |
| Q3 2024 | -0.2x | Net Cash |
BABA's net debt is less than a year of its operating earnings (EBITDA).
CALY Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -3.2x | Net Cash |
| Q2 2026 | -1.5x | Net Cash |
| Q1 2026 | -0.1x | Net Cash |
| Q4 2025 | 2.9x | Moderate |
| Q3 2024 | 2.5x | Moderate |
| Q2 2024 | 2.6x | Moderate |
| Q1 2024 | 2.9x | Moderate |
| Q4 2023 | 2.5x | Moderate |
CALY has the edge over BABA on leverage, with a lower net debt burden relative to earnings.
BABA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.0 | Neutral |
| Stochastic | 12.7 | Oversold |
BABA's weekly RSI is 38 (neutral) and its Stochastic is 13 (oversold).
CALY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.0 | Neutral |
| Stochastic | 51.0 | Neutral |
CALY's weekly RSI is 56 (neutral) and its Stochastic is 51 (neutral).
BABA PE vs Consumer Cyclical Sector
| Metric | BABA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 18x | 19% above |
| PE % | 60 | 47 | 13 pts above |
BABA is trading at 21x earnings, a 19% premium to the Consumer Cyclical sector's median of 18x, though its earnings don't support one.
CALY PE vs Consumer Cyclical Sector
| Metric | CALY | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 18x | — |
CALY has no meaningful PE right now: it lost money over the past year.
BABA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $104.7 | 9.9% below |
| 20 week MA | $111.1 | 15% below |
| 50 week MA | $128.0 | 26% below |
| 100 week MA | $127.7 | 26% below |
| 200 week MA | $106.4 | 11% below |
BABA is in a downtrend: it's below all five of its weekly moving averages, and 11% below its 200-week average.
CALY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $14.9 | 11% above |
| 20 week MA | $16.2 | 2.5% above |
| 50 week MA | $15.1 | 9.5% above |
| 100 week MA | $11.7 | 42% above |
| 200 week MA | $13.6 | 22% above |
CALY has the edge over BABA on trend strength, trading above more of its moving averages.
BABA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $215.5 | $222.0 | +3% |
| 2021 | $222.0 | $118.7 | -47% |
| 2022 | $118.7 | $85.7 | -28% |
| 2023 | $85.7 | $77.5 | -9.5% |
| 2024 | $77.5 | $85.1 | +9.7% |
| 2025 | $85.1 | $152.2 | +79% |
| 2026 YTD | $152.2 | $94.4 | -38% |
BABA has finished lower in three of the last six years. It's down 38% so far in 2026.
CALY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $20.9 | $24.4 | +17% |
| 2021 | $24.4 | $27.0 | +11% |
| 2022 | $27.0 | $19.7 | -27% |
| 2023 | $19.7 | $14.3 | -27% |
| 2024 | $14.3 | $7.72 | -46% |
| 2025 | $7.72 | $11.7 | +52% |
| 2026 YTD | $11.7 | $16.6 | +41% |
CALY has the edge over BABA on returns for 2026, with the stronger performance.